brand logo

Fam Pract Manag. 2023;30(1):28

Author disclosure: no relevant financial affiliations.

COMPARING TEST DATA FROM PREVIOUS VISIT

MODIFIER JW FOR UNUSED MEDICATION

vial needle

It is advisable to check individual payer policies for specific reporting instructions. Not all payers recognize the JW modifier, and some require that you provide additional information such as the product's National Drug Code (NDC) and NDC units (which are often different from HCPCS drug units). Some plans also require that you consider the smallest available drug unit that would provide the required dose of medication with the least waste. For example, Drug A is available in 30 mg or 60 mg single-use vials. You administer 20 mg and report 10 mg as wasted by appending modifier JW even though you provided it from a 60 mg single-use vial.

ADMINISTRATION OF MEDICATION BOUGHT OUTSIDE THE PRACTICE

PROVIDING PRESCRIPTION DRUG SAMPLES DURING E/M VISIT

TESTS CONSIDERED BUT NOT ORDERED

WE WANT TO HEAR FROM YOU

Send questions and comments to fpmedit@aafp.org, or add your comments below. While this department attempts to provide accurate information, some payers may not accept the advice given. Refer to the current CPT and ICD-10 coding manuals and payer policies.

Continue Reading


More in FPM

Copyright © 2023 by the American Academy of Family Physicians.

This content is owned by the AAFP. A person viewing it online may make one printout of the material and may use that printout only for his or her personal, non-commercial reference. This material may not otherwise be downloaded, copied, printed, stored, transmitted or reproduced in any medium, whether now known or later invented, except as authorized in writing by the AAFP.  See permissions for copyright questions and/or permission requests.